story of the week
70-Gene Signature as an Aid for Treatment Decisions in Early Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
70-Gene Signature as an Aid for Treatment Decisions in Early Breast Cancer: Updated Results of the Phase 3 Randomised MINDACT Trial With an Exploratory Analysis by Age
Lancet Oncol 2021 Mar 12;[EPub Ahead of Print], M Piccart, LJ van 't Veer, C Poncet, JMN Lopes Cardozo, S Delaloge, JY Pierga, P Vuylsteke, E Brain, S Vrijaldenhoven, PA Neijenhuis, S Causeret, TJ Smilde, G Viale, AM Glas, M Delorenzi, C Sotiriou, IT Rubio, S Kümmel, G Zoppoli, AM Thompson, E Matos, K Zaman, F Hilbers, D Fumagalli, P Ravdin, S Knox, K Tryfonidis, A Peric, B Meulemans, J Bogaerts, F Cardoso, EJT RutgersFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.